Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Urogynecology Journal|September 11, 2015
Female urinary incontinence health information quality on the Internet: a multilingual evaluationIshani Saraswat, Robert Abouassaly, Peter Dwyer, et al.
International Urogynecology Journal|November 27, 2013
A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndromeJane Manning, Peter Dwyer, Anna Rosamilia, et al.
International Urogynecology Journal|May 5, 2010
Do the Advantage slings work as well as the tension-free vaginal tapes?Yik N Lim, Peter Dwyer, Reinhold Muller, et al.
International Urogynecology Journal|December 18, 2016
Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndromeYik N Lim, Peter Dwyer, Christine Murray, et al.
Neurourology and Urodynamics|July 30, 2008
Long-term benefits of darifenacin treatment for patient quality of life: results from a 2-year extension studyPeter Dwyer, Con Kelleher, Jay Young, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|April 7, 2006
Validation of a simplified technique for using the POPQ pelvic organ prolapse classification systemSteven Swift, Sarah Morris, Vikki McKinnie, et al.
International Urogynecology Journal|June 23, 2022
Long-term functional results of transvaginal anal sphincter repair for faecal incontinence; a retrospective case seriesFrida Carswell, Peter Dwyer, Ariel Zilberlicht, et al.
BJU International|August 2, 2006
Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension studyFrançois Haab, Jacques Corcos, Paul Siami, et al.
International Urogynecology Journal|January 16, 2021
Efficacy of Clorpactin in refractory bladder pain syndrome/interstitial cystitis: a randomized controlled trialKristina Cvach, Anna Rosamilia, Peter Dwyer, et al.
Mitochondrion|February 20, 2018
PPARδ modulation rescues mitochondrial fatty acid oxidation defects in the mdx model of muscular dystrophyEric L Bell, Robert W Shine, Peter Dwyer, et al.
Pageof 3